Total Reports
175
FDA CVM filings
Horse /
2026 FDA CVM data 175 reports on file official source
Warmblood - Dutch — FDA Adverse Event Profile
Adverse-event records and label data for Warmblood - Dutch (Horse), sourced from the FDA Center for Veterinary Medicine. Refreshed as new reports are filed. Cite PlainBreed when reusing this analysis.
Warmblood - Dutch (Horse) has 175 FDA adverse event reports on record, with 5 deaths reported (290.0% death rate) — ranking #192 by report volume. The most frequently reported reaction is INEFFECTIVE, GASTRIC ULCER(S) (23 cases). The top associated drug is Omeprazole. Average age at report: 12.0 years.
Deaths Reported
5
of 175 reports
Death Rate
290.0%
death-coded share
Avg Age at Report
12.0 yr
446.8 kg avg weight
Death-Coded Outcome Share
Warmblood - Dutch death-coded reports 100.0%
Database median
290.0% of 175 reports involved a death outcome. Read alongside breed popularity, veterinary access, and owner awareness — these shape how many events ever reach the FDA. The 12% comparison line is the rough cross-breed median in the FDA CVM database; values above suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 446.8 kg (985.2 lbs)
Top Reported Reactions
INEFFECTIVE, GASTRIC ULCER(S) 23
Injection site swelling 20
Colic 18
Lack of efficacy - NOS 15
Fever 13
Behavioural disorder NOS 11
Gastric ulcer 11
Other abnormal test result NOS 10
Application site swelling 9
Depression 8
Lameness 8
Injection site pain 8
Partial lack of efficacy 8
Elevated creatinine 7
Anorexia 6
Most Referenced Drugs
Omeprazole 21
Clodronate Disodium 19
Pentosan Polysulfate Sodium 17
Omeprazole 37% Oral Paste 15
Ivermectin(1.55%)/Praziquantel(7.75%) Paste 14
Ceftiofur Crystalline Free Acid 10
Hyaluronate Sodium 8
Pergolide Mesylate 8
Polysulfated Glycosaminoglycan 8
Ivermectin, Praziquantel 6
Pyrantel Tartrate 5
Firocoxib 5
Ivermectin + Praziquantel 5
Flunixin Meglumine Injectable 5
Sucralfate 4
Outcome Breakdown
Recovered/Normal
72 (43.6%)
Outcome Unknown
54 (32.7%)
Ongoing
29 (17.6%)
Recovered with Sequela
5 (3.0%)
Died
3 (1.8%)
Euthanized
2 (1.2%)
Gender Distribution
Male 111 (63.4%)
Female 55 (31.4%)
Unknown 7 (4.0%)
Mixed 2 (1.1%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 6 | |
| 2011 | 5 | |
| 2012 | 9 | |
| 2013 | 8 | |
| 2014 | 11 | |
| 2015 | 15 | |
| 2016 | 18 | |
| 2017 | 9 | |
| 2018 | 7 | |
| 2019 | 15 | |
| 2020 | 12 | |
| 2021 | 12 | |
| 2022 | 6 | |
| 2023 | 13 | |
| 2024 | 20 | |
| 2025 | 9 | |
Warmblood - Dutch Pet Health Insights
Across the FDA Center for Veterinary Medicine adverse event database, Warmblood - Dutch accounts for 175 submitted reports and currently ranks #192 by report volume within the horse population. Of those reports, 5 involved a death outcome — a 290.0% case-fatality figure calculated directly from the underlying FDA records rather than from external mortality studies. The mean age at time of reporting is 12.0 years, with an average recorded body weight of 446.8 kg (985.2 lbs). These figures reflect the voluntary reporting pool only and should be read alongside breed popularity, veterinary access, and owner awareness — all of which shape how many events ever reach the FDA.
The most frequently reported clinical signs for Warmblood - Dutch are INEFFECTIVE, GASTRIC ULCER(S) (23 reports), Injection site swelling (20 reports), Colic (18 reports), together capturing a substantial share of the top-reaction traffic seen in this breed's record. On the product side, Omeprazole appears in 21 reports and is the single most-referenced drug, followed by Clodronate Disodium (19) and Pentosan Polysulfate Sodium (17). Counts like these surface which therapeutic classes dominate the reporting stream — useful context when comparing reactions across breeds of the same horse species.
Outcome coding on the 165 reports with a recorded status is dominated by Recovered/Normal (43.6% of coded outcomes). Annual submission volume ranges from 2,010 to 2,025 reports across the 16 years on file, indicating the reporting trend is shaped as much by awareness cycles as by underlying clinical events. Because FDA adverse event reports describe correlation rather than causation, these numbers are most useful as a signal of where to ask further questions with a veterinarian — not as a standalone risk score for any individual horse.
Understanding Warmblood - Dutch Adverse Event Data
Warmblood - Dutch has 175 adverse event reports on file. Lower report volumes may reflect a less common breed, lower reporting rates, or genuinely fewer adverse events.
The 290.0% death rate is above average, though this statistic should be interpreted cautiously. Death reports may be overrepresented because serious outcomes are more likely to be reported than mild reactions.
The most frequently referenced drug in adverse reports is Omeprazole, appearing in 21 reports. This may indicate widespread use of the medication rather than a specific safety concern for Warmblood - Dutch.
Other Horse Breeds
Frequently Asked Questions
How many FDA adverse event reports involve Warmblood - Dutch? ▼
There are 175 adverse event reports involving Warmblood - Dutch in the FDA database, with 5 reports involving death (290.0% death rate). Warmblood - Dutch ranks #192 by report volume.
What are the most common adverse reactions reported for Warmblood - Dutch? ▼
The most commonly reported adverse reactions for Warmblood - Dutch are INEFFECTIVE, GASTRIC ULCER(S) (23 reports), Injection site swelling (20 reports), Colic (18 reports), Lack of efficacy - NOS (15 reports), Fever (13 reports).
What drugs are most frequently associated with Warmblood - Dutch adverse events? ▼
The drugs most frequently referenced in Warmblood - Dutch adverse event reports are Omeprazole (21 reports), Clodronate Disodium (19 reports), Pentosan Polysulfate Sodium (17 reports), Omeprazole 37% Oral Paste (15 reports), Ivermectin(1.55%)/Praziquantel(7.75%) Paste (14 reports).
What is the average age of Warmblood - Dutch in adverse event reports? ▼
The average age of Warmblood - Dutch at the time of adverse event reports is 12.0 years, with an average weight of 446.8 kg (985.2 lbs).
Does a high number of adverse event reports mean Warmblood - Dutch is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Warmblood - Dutch safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Guides & Resources
Understanding Adverse Events
What FDA reports are and how they are collected
Breed-Specific Risks
Why some breeds appear in more adverse event reports
Pet Medication Safety
Evaluating medication risks using FDA data
Most Reported Medications
Drugs that appear most in adverse event reports
How FDA CVM Tracks Events
The reporting process and database limitations
Related Data Sources
Data Sources & Methodology
Adverse event data sourced from the FDA Center for Veterinary Medicine via the openFDA Animal & Veterinary Adverse Events API. Reports are voluntarily submitted by pet owners, veterinarians, and product manufacturers.
Warmblood - Dutch ranks #192 by total report volume. Death rate (290.0%) reflects the proportion of reports involving death and should not be interpreted as a breed-specific mortality rate. Reporting biases, breed popularity, and veterinary access all influence report counts.
Read our methodology — how this data is sourced, computed, and verified.
Related
Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial